146 According to a report by the Center for Data Innovation, telehealth companies have been using advertising loopholes to promote stimulant medications to users on social media without the usual disclosures found in pharmaceutical ads. These companies are able to post ads for prescription drugs without including warnings or information about side effects due to discrepancies in pharmaceutical advertising laws and regulations. Many of the ads for stimulant medication on social media are targeted at individuals concerned about Attention Deficit and Hyperactivity Disorders. You Might Be Interested In HDFC Bank Pursues Singapore Banking License in Strategic Move to Tap Indian Diaspora Abroad Tesla Gears Up for Giant Factory Expansion in Texas J.P. Morgan Appoints Harshika Patel as CEO of Asia Private Bank and Kam Shing Kwang as Chairwoman of North Asia Reliance Finalizes Acquisition of American Alloy Steel Regional payment connectivity expansion to include the State Bank of Vietnam Molina Healthcare Wins Michigan Medicaid Contract
